Research ExplorerPublicationsSphingosine-1-phosphate and vascular disease in the general ...

Sphingosine-1-phosphate and vascular disease in the general population

Standard

Sphingosine-1-phosphate and vascular disease in the general population. / Rotheudt, Luisa; Moritz, Eileen; Markus, Marcello R P; Albrecht, Diana; Völzke, Henry; Friedrich, Nele; Schwedhelm, Edzard; Daum, Günter; Schminke, Ulf; Felix, Stephan B; Rauch, Bernhard H; Dörr, Marcus; Bahls, Martin.

In: ATHEROSCLEROSIS, Vol. 350, 06.2022, p. 73-81.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Rotheudt, L, Moritz, E, Markus, MRP, Albrecht, D, Völzke, H, Friedrich, N, Schwedhelm, E, Daum, G, Schminke, U, Felix, SB, Rauch, BH, Dörr, M & Bahls, M 2022, 'Sphingosine-1-phosphate and vascular disease in the general population', ATHEROSCLEROSIS, vol. 350, pp. 73-81. https://doi.org/10.1016/j.atherosclerosis.2022.03.020

APA

Rotheudt, L., Moritz, E., Markus, M. R. P., Albrecht, D., Völzke, H., Friedrich, N., Schwedhelm, E., Daum, G., Schminke, U., Felix, S. B., Rauch, B. H., Dörr, M., & Bahls, M. (2022). Sphingosine-1-phosphate and vascular disease in the general population. ATHEROSCLEROSIS, 350, 73-81. https://doi.org/10.1016/j.atherosclerosis.2022.03.020

Vancouver

Rotheudt L, Moritz E, Markus MRP, Albrecht D, Völzke H, Friedrich N et al. Sphingosine-1-phosphate and vascular disease in the general population. ATHEROSCLEROSIS. 2022 Jun;350:73-81. https://doi.org/10.1016/j.atherosclerosis.2022.03.020

Bibtex

@article{136496284aca4bd09a4f5aa8295dcda2,
title = "Sphingosine-1-phosphate and vascular disease in the general population",
abstract = "BACKGROUND AND AIMS: Sphingosine-1-phosphate (S1P) is a sphingolipid which influences the immune and vascular system. The relationship between S1P and vascular disease in the general population is currently unclear. We explored the relation between S1P and vascular markers, (i.e. ankle-brachial index (ABI), carotid intima-media thickness (cIMT), presence of carotid atherosclerotic plaques and brachial artery flow-mediated dilation (FMD).METHODS: S1P was measured by liquid chromatography-tandem mass spectrometry in the population-based Study of Health in Pomerania (SHIP-TREND-0). Subjects with prevalent cancer, severe renal insufficiency, history of myocardial infarction and extreme values for S1P were excluded. Sex stratified linear regression models adjusted for age, smoking and waist-to-hip ratio were used.RESULTS: A total of n = 3643 participants (52% women, median age 51, 25th and 75th percentiles 39 and 63 years) were included. In men, a 1 standard deviation higher S1P concentration was associated with a significantly greater cIMT (β: 0.0057 95%-confidence interval [CI]: 0.00027-0.0112 mm; p = 0.04) and a lower ABI (β: -0.0090 95% CI: -0.0153 to -0.0029; p < 0.01). In women, S1P was also positively associated with cIMT (β: 0.0044 95% CI: 0.0001-0.0086 mm; p = 0.04).CONCLUSIONS: We found that S1P was positively related to a greater cIMT in both sexes and a lower ABI in men. There was no association of S1P with any of the other investigated markers. Future studies are warranted to assess the suitability of S1P as a biomarker for vascular disease.",
keywords = "Ankle Brachial Index, Carotid Intima-Media Thickness, Female, Humans, Lysophospholipids, Male, Risk Factors, Sphingosine/analogs & derivatives, Vascular Diseases",
author = "Luisa Rotheudt and Eileen Moritz and Markus, {Marcello R P} and Diana Albrecht and Henry V{\"o}lzke and Nele Friedrich and Edzard Schwedhelm and G{\"u}nter Daum and Ulf Schminke and Felix, {Stephan B} and Rauch, {Bernhard H} and Marcus D{\"o}rr and Martin Bahls",
note = "Copyright {\textcopyright} 2022 Elsevier B.V. All rights reserved.",
year = "2022",
month = jun,
doi = "10.1016/j.atherosclerosis.2022.03.020",
language = "English",
volume = "350",
pages = "73--81",
journal = "ATHEROSCLEROSIS",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Sphingosine-1-phosphate and vascular disease in the general population

AU - Rotheudt, Luisa

AU - Moritz, Eileen

AU - Markus, Marcello R P

AU - Albrecht, Diana

AU - Völzke, Henry

AU - Friedrich, Nele

AU - Schwedhelm, Edzard

AU - Daum, Günter

AU - Schminke, Ulf

AU - Felix, Stephan B

AU - Rauch, Bernhard H

AU - Dörr, Marcus

AU - Bahls, Martin

N1 - Copyright © 2022 Elsevier B.V. All rights reserved.

PY - 2022/6

Y1 - 2022/6

N2 - BACKGROUND AND AIMS: Sphingosine-1-phosphate (S1P) is a sphingolipid which influences the immune and vascular system. The relationship between S1P and vascular disease in the general population is currently unclear. We explored the relation between S1P and vascular markers, (i.e. ankle-brachial index (ABI), carotid intima-media thickness (cIMT), presence of carotid atherosclerotic plaques and brachial artery flow-mediated dilation (FMD).METHODS: S1P was measured by liquid chromatography-tandem mass spectrometry in the population-based Study of Health in Pomerania (SHIP-TREND-0). Subjects with prevalent cancer, severe renal insufficiency, history of myocardial infarction and extreme values for S1P were excluded. Sex stratified linear regression models adjusted for age, smoking and waist-to-hip ratio were used.RESULTS: A total of n = 3643 participants (52% women, median age 51, 25th and 75th percentiles 39 and 63 years) were included. In men, a 1 standard deviation higher S1P concentration was associated with a significantly greater cIMT (β: 0.0057 95%-confidence interval [CI]: 0.00027-0.0112 mm; p = 0.04) and a lower ABI (β: -0.0090 95% CI: -0.0153 to -0.0029; p < 0.01). In women, S1P was also positively associated with cIMT (β: 0.0044 95% CI: 0.0001-0.0086 mm; p = 0.04).CONCLUSIONS: We found that S1P was positively related to a greater cIMT in both sexes and a lower ABI in men. There was no association of S1P with any of the other investigated markers. Future studies are warranted to assess the suitability of S1P as a biomarker for vascular disease.

AB - BACKGROUND AND AIMS: Sphingosine-1-phosphate (S1P) is a sphingolipid which influences the immune and vascular system. The relationship between S1P and vascular disease in the general population is currently unclear. We explored the relation between S1P and vascular markers, (i.e. ankle-brachial index (ABI), carotid intima-media thickness (cIMT), presence of carotid atherosclerotic plaques and brachial artery flow-mediated dilation (FMD).METHODS: S1P was measured by liquid chromatography-tandem mass spectrometry in the population-based Study of Health in Pomerania (SHIP-TREND-0). Subjects with prevalent cancer, severe renal insufficiency, history of myocardial infarction and extreme values for S1P were excluded. Sex stratified linear regression models adjusted for age, smoking and waist-to-hip ratio were used.RESULTS: A total of n = 3643 participants (52% women, median age 51, 25th and 75th percentiles 39 and 63 years) were included. In men, a 1 standard deviation higher S1P concentration was associated with a significantly greater cIMT (β: 0.0057 95%-confidence interval [CI]: 0.00027-0.0112 mm; p = 0.04) and a lower ABI (β: -0.0090 95% CI: -0.0153 to -0.0029; p < 0.01). In women, S1P was also positively associated with cIMT (β: 0.0044 95% CI: 0.0001-0.0086 mm; p = 0.04).CONCLUSIONS: We found that S1P was positively related to a greater cIMT in both sexes and a lower ABI in men. There was no association of S1P with any of the other investigated markers. Future studies are warranted to assess the suitability of S1P as a biomarker for vascular disease.

KW - Ankle Brachial Index

KW - Carotid Intima-Media Thickness

KW - Female

KW - Humans

KW - Lysophospholipids

KW - Male

KW - Risk Factors

KW - Sphingosine/analogs & derivatives

KW - Vascular Diseases

U2 - 10.1016/j.atherosclerosis.2022.03.020

DO - 10.1016/j.atherosclerosis.2022.03.020

M3 - SCORING: Journal article

C2 - 35533519

VL - 350

SP - 73

EP - 81

JO - ATHEROSCLEROSIS

JF - ATHEROSCLEROSIS

SN - 0021-9150

ER -